Observational Study
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. May 26, 2023; 11(15): 3491-3501
Published online May 26, 2023. doi: 10.12998/wjcc.v11.i15.3491
Observation of the effect of angiojet to treat acute lower extremity arterial embolization
Xiao-Hu Meng, Xu-Pin Xie, Yong-Chang Liu, Chang-Pin Huang, Lin-Jun Wang, Han-Yi Liu, Xin Fang, Guo-Hui Zhang
Xiao-Hu Meng, Xu-Pin Xie, Yong-Chang Liu, Lin-Jun Wang, Han-Yi Liu, Department of Vascular Surgery, The Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, Zhejiang Province, China
Chang-Pin Huang, Guo-Hui Zhang, Department of General Surgery, The Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310022, Zhejiang Province, China
Xin Fang, Department of Vascular Surgery, The Affiliated Hangzhou Cancer Hospital, Zhejiang University School of Medicine, Hangzhou 310006, Zhejiang Province, China
Author contributions: Meng XH contributed to the study conception and writing; Meng XH and Zhang GH contributed to the data collection and investigation; Meng XH and Xie XP contributed to the analysis; all authors contributed to the critical review and revision, final approval of the article and accountability for all aspects of the work.
Supported by Hangzhou Medical Health Science and Technology Project, No. 20220919Y001; and No. 20220919Y004.
Institutional review board statement: The study was reviewed and approved by the Hangzhou First People's Hospital Institutional Review Board (Approval No.ⅡT-20221218-0201-01).
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: All authors have no conflict of interest.
Data sharing statement: No additional data are available.
STROBE statement: The authors have read the STROBE Statement—checklist of items, and the manuscript was prepared and revised according to the STROBE Statement—checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Guo-Hui Zhang, MBChB, Nurse, Department of General Surgery, The Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, No. 469 Shenban Road, Hangzhou 310022, Zhejiang Province, China. 1018885878@qq.com
Received: January 25, 2023
Peer-review started: January 25, 2023
First decision: March 14, 2023
Revised: March 25, 2023
Accepted: April 13, 2023
Article in press: April 13, 2023
Published online: May 26, 2023
Processing time: 120 Days and 13 Hours
Core Tip

Core Tip: Acute lower extremity arterial embolism is a common clinical emergency. It has the characteristics of rapid onset and rapid development. If left untreated, irreversible damage to limb tissue can occur within hours. Therefore, the key to the treatment of acute lower extremity arterial embolism is to seize the time and implement effective treatment plan is of great significance. Angiojet thrombectomy is a minimally invasive technique to remove thrombectomy through percutaneous insertion of catheters. The objective of this study was to investigate the application effect of angiojet thrombectomy in the treatment of acute lower extremity arterial embolization.